Viewing StudyNCT00414440



Ignite Creation Date: 2024-05-05 @ 5:13 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00414440
Status: COMPLETED
Last Update Posted: 2015-01-14
First Post: 2006-12-20

Brief Title: Efficacy Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-12
Start Date Type: None
Primary Completion Date: 2013-10
Primary Completion Date Type: ACTUAL
Completion Date: 2013-10
Completion Date Type: ACTUAL
First Submit Date: 2006-12-20
First Submit QC Date: December 20 2006
Study First Post Date: 2006-12-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2015-01-14
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-01-13
Last Update Post Date: 2015-01-14
Last Update Post Date Type: ESTIMATED